Morgan Stanley Downgrades Novo Nordisk (NVO) to Equalweight
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Morgan Stanley yesterday downgraded Novo Nordisk (NYSE: NVO) from Overweight to Equalweight.
Shares of Novo Nordisk closed at $46.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades United Rentals (URI) to Equalweight
- Credit Suisse Downgrades Everyday Health (EVDY) to Neutral Following Takeover
- Deutsche Bank Downgrades Brown & Brown (BRO) to Hold
Create E-mail Alert Related CategoriesDowngrades
Related EntitiesMorgan Stanley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!